Table 5 Clinical characteristics of patients grouped by carotid ultrasonography
|  | Normal IMT (n = 160) | Increased IMT (n = 1356) | P |
|---|---|---|---|
Male (n%) | 40 (25.0) | 692 (51.0) | 0.000 |
Age (years) | 57 (52, 63) | 64 (59, 69) | 0.000 |
BMI (kg/m2) | 24.7 (23.0, 27.3) | 25.2 (23.4, 27.7) | 0.231 |
TyG index (n%) | 0.007 | ||
 T1 (n = 552) (lowest) | 57 (35.6) | 322 (23.7) | |
 T2 (n = 551) | 40 (25.0) | 339 (25.0) | |
 T3 (n = 552) | 33 (20.6) | 346 (25.5) | |
 T4 (n = 552) (highest) | 30 (18.8) | 349 (25.7) | |
SBP (mmHg) | 130 (120, 140) | 133 (122, 144) | 0.002 |
TC (mmol/L) | 4.5 (4.0, 5.1) | 4.4 (3.7, 5.2) | 0.199 |
LDL-C (mmol/L) | 2.7 (2.2, 3.3) | 2.7 (2.1, 3.3) | 0.967 |
HDL-C(mmol/L) | 1.2 (1.0, 1.4) | 1.1 (1.0, 1.3) | 0.000 |
PLT (*109/L) | 210 (184, 253) | 211 (183, 251) | 0.998 |
HbA1C (%) | 5.8 (5.5, 6.2) | 6.1 (5.7, 6.8) | 0.000 |
Hypertension (n%) | 70 (43.8) | 917 (67.6) | 0.000 |
Diabetes (n%) | 33 (20.6) | 426 (31.4) | 0.005 |
Smoking (n%) | 28 (17.5) | 561 (41.4) | 0.000 |
Use of antilipemic agents (n%) | 28 (17.5) | 325 (24.0) | 0.067 |
Use of antidiabetic agents (n%) | 26 (16.3) | 350 (25.8) | 0.008 |